---
figid: PMC5903677__nihms953569f3
figlink: /pmc/articles/PMC5903677/figure/F3/
number: F3
caption: Therapeutic targets for brain injury for nanoparticle mediated drug delivery.
  Brain injury leads to a cascade of secondary damage events (denoted in grey boxes).
  These secondary injuries are potential targets for therapeutics where NP delivery
  may be useful. Potential interventions strategies are highlighted with red/green/blue
  font where inhibitors/blocking agents are in red, neuroprotective agents via pathway
  modulation in green, and targeting ligands in blue.
pmcid: PMC5903677
papertitle: Nanoparticle-based therapeutics for brain injury.
reftext: Vimala N. Bharadwaj, et al. Adv Healthc Mater. ;7(1):10.1002/adhm.201700668.
pmc_ranked_result_index: '73941'
pathway_score: 0.7258392
filename: nihms953569f3.jpg
figtitle: Therapeutic targets for brain injury for nanoparticle mediated drug delivery
year: ''
organisms: Homo sapiens
ndex: f0a36fc0-df28-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5903677__nihms953569f3.html
  '@type': Dataset
  description: Therapeutic targets for brain injury for nanoparticle mediated drug
    delivery. Brain injury leads to a cascade of secondary damage events (denoted
    in grey boxes). These secondary injuries are potential targets for therapeutics
    where NP delivery may be useful. Potential interventions strategies are highlighted
    with red/green/blue font where inhibitors/blocking agents are in red, neuroprotective
    agents via pathway modulation in green, and targeting ligands in blue.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FASLG
  - CASP2
  - CASP12
  - EPO
  - CASP8
  - CASP10
  - NPS
  - CASP1
  - CASP14
  - CASP9
  - BDNF
  - CASP6
  - CASP7
  - CASP5
  - CASP4
  - CASP3
  - Citicoline
  - Adenosine
  - Glutamate
  - Brain Injury
  - Edema
  - Necrosis
genes:
- word: +FasL
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: +EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: NPs
  symbol: NPS
  source: hgnc_symbol
  hgnc_symbol: NPS
  entrez: '594857'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
chemicals:
- word: Citicoline
  source: MESH
  identifier: D003566
- word: Adenosine
  source: MESH
  identifier: D000241
- word: Glutamate
  source: ''
  identifier: ''
diseases:
- word: Brain Injury
  source: MESH
  identifier: D001927
- word: Edema
  source: MESH
  identifier: D004487
- word: Necrosis
  source: MESH
  identifier: D009336
figid_alias: PMC5903677__F3
redirect_from: /figures/PMC5903677__F3
figtype: Figure
---
